Transcorp Intl. (532410)
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 1/1
Key Financials
| Current Price | ₹33.35 |
| Market Cap | ₹106.24 Cr |
| P/E Ratio | 13.24 |
| ROCE | 17.06% |
| ROE | 8.31% |
| Dividend Yield | 2.35% |
| Profit Growth | 212.18% |
| Debt/Equity | — |
| Sales Growth | -27.56% |
| 52-Week Range | ₹21.3 — ₹34.24 |
| Sector | Finance |
| Book Value | ₹17.01 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹33.35, Transcorp Intl is a ₹106 Cr micro-cap in financial services. Ben Graham would tell me to weigh facts, not hopes. The facts are mixed: a P/E of 13.24 looks reasonable, and a 2.35% dividend yield gives some comfort. But I cannot ignore a 27.56% decline in sales; a business that shrinks rarely becomes more valuable. The 212.18% profit growth sounds impressive, but the latest quarter shows only ₹2 Cr net profit on ₹211 Cr sales—a thin, fragile margin. This is not evidence of a durable franchise. ROE of 8.31% is below what I expect from a quality compounder, even though ROCE of 17.06% suggests operating assets earn decent returns. A price-to-book of 1.96 is hardly a bargain for a business earning such modest returns on equity. With promoter holding and debt/equity not disclosed, I cannot fully judge governance or leverage, which is itself a yellow flag. The Piotroski F-Score of 6/9 says finances are okay, but no more. A PEG of 0.06 is misleading when past earnings are distorted and sales are falling. This may be a turnaround, but I prefer businesses whose current success is visible and sustainable. I would not buy without seeing revenue stabilize and profit margins expand. If I enter at all, it would be a small position with a wide margin of safety and strict monitoring.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer